| Literature DB >> 31997901 |
Maged S Abdel-Kader1,2, Gamal A Soliman3,4, Mohammed H Alqarni1, Abubaker M Hamad5,6, Ahmed I Foudah1, Saleh I Alqasoumi7.
Abstract
The hepatoprotective activity of the total extract of Juniperus sabina L. against CCl4 induced toxicity in experimental animals was previously reported and indicated promising results. Essential oil of J. Sabina was prepared by hydrodistillation method. Components of the oil were identified by comparison of GC-MS and retention indexes with reported data. The hepatoprotective effect of the essential oil against CCl4 induced toxicity was studied using male Wistar rats and silymarin at 10 mg/kg p.o as standard drug. The protective effect was evaluated via serum biochemical parameters such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyltranspeptidase (GGT), and total bilirubin as well as tissue parameters including non-protein sulfhydryl groups (NP-SH), malonaldehyde (MDA) and total protein (TP). Histopathological study was applied on the liver tissues using Mayer's hematoxylin stain, Periodic Acid Schiff - Hematoxylin (PAS-H) and Masson trichrome technique on light microscope. Electron microscope images were also obtained for more detailed study.Entities:
Keywords: Biochemical parameters; Electron microscope; Essential oil; Hepatoprotective; Juniperus sabina
Year: 2019 PMID: 31997901 PMCID: PMC6978616 DOI: 10.1016/j.jsps.2019.07.003
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Composition of the essential oil of J. sabina.
| No | Name | RRI | % |
|---|---|---|---|
| 1 | α-Thujene | 928 | 1.430 |
| 2 | α-Pinene | 940 | 5.210 |
| 3 | Sabinene | 975 | 55.820 |
| 4 | 1024 | 1.160 | |
| 5 | 986 | 0.540 | |
| 6 | Myrcene | 992 | 1.150 |
| 7 | Limonene | 1029 | 0.500 |
| 8 | 1071 | 0.160 | |
| 9 | Carvone | 1089 | 0.280 |
| 10 | Linalool | 1101 | 0.420 |
| 11 | α-Thujone | 1108 | 0.380 |
| 12 | Verbenone | 1120 | 0.540 |
| 13 | Limomene oxide | 1137 | 0.520 |
| 14 | 1140 | 0.990 | |
| 15 | Pinocarvone | 1161 | 0.830 |
| 16 | α-Terpineol | 1190 | 0.340 |
| 17 | 1205 | 0.560 | |
| 18 | Geraneol | 1229 | 0.530 |
| 19 | Citronellol | 1232 | 1.040 |
| 20 | Linalyl acetate | 1235 | 2.210 |
| 21 | 1256 | 0.350 | |
| 22 | α-terpinyl acetate | 1335 | 1.280 |
| 23 | Elemene | 1393 | 0.680 |
| 24 | 1421 | 0.750 | |
| 25 | α-Humulene | 1454 | 0.45 |
| 26 | α-Muurolene | 1477 | 1.070 |
| 27 | Cadinene | 1515 | 0.420 |
| 28 | 1546 | 7.900 | |
| 29 | α-Calacorene | 1563 | 0.220 |
| 30 | Dodecanoic acid | 1569 | 1.070 |
| 31 | Caryophyllene oxide | 1582 | 1.480 |
| 32 | Humulene oxide | 1610 | 1.070 |
| 33 | 1644 | 2.970 | |
| 34 | Cadalene | 1673 | 1.110 |
| 35 | Calamenene-10 | 1689 | 0.850 |
| 36 | Calamenene-10 α-ol | 1697 | 0.790 |
| Total% | 97.07 | ||
Effect of J. Sabina oil on the serum levels of liver injury markers in CCl4-intoxicated rats.
| Treatment | AST (U/L) | ALT (U/L) | GGT(U/L) | ALP(U/L) | Bilirubin(mg/dl) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± S.E | % Change | Mean ± S.E | % Change | Mean ± S.E | % Change | Mean ± S.E | % Change | Mean ± S.E | % Change | |
| Control | 113.00 ± 4.08 | 31.45 ± 2.05 | 4.10 ± 0.17 | 357.00 ± 18.49 | 0.55 ± 0.02 | |||||
| CCl4 | 296.75 ± 7.72* | 225.25 ± 12.45* | 15.02 ± 0.33* | 596.50 ± 11.54* | 2.93 ± 0.07* | |||||
| Silymarin | 139.00 ± 7.16* | 53.15 | 77.62 ± 16.46* | 65.53 | 6.50 ± 0.30* | 56.73 | 411.50 ± 25.10* | 31.01 | 1.04 ± 0.12* | 64.27 |
| 50 mg/kg | 283.75 ± 7.49 | 4.38 | 218.00 ± 8.79 | 3.12 | 14.22 ± 0.42 | 5.32 | 542.00 ± 7.22* | 9.13 | 2.62 ± 0.11 | 10.65 |
| 100 mg/kg | 280.25 ± 6.12 | 5.56 | 184.75 ± 8.75* | 17.98 | 13.40 ± 0.31* | 10.81 | 533.25 ± 9.10* | 10.60 | 2.44 ± 0.02* | 16.53 |
| 150 mg/kg | 237.50 ± 8.30* | 19.96 | 152.75 ± 6.53* | 32.18 | 11.30 ± 0.31* | 24.79 | 485.00 ± 7.71* | 18.69 | 2.00 ± 0.19* | 31.79 |
| 200 mg/kg | 188.00 ± 9.03* | 36.64 | 129.75 ± 4.78* | 43.39 | 10.45 ± 0.31* | 30.44 | 446.75 ± 7.57* | 25.10 | 1.37 ± 0.06* | 53.11 |
All values represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ANOVA, followed by Dunnett’s multiple comparison test.
As compared with Control group.
As compared with CCl4 only group.
Effect of J. sabina oil on MDA, NP-SH and Total protein in liver tissue of CCl4-intoxicated rats.
| Treatment | MDA (nmol/g) | NP-SH (nmol/g) | TP (g/l) |
|---|---|---|---|
| Control | 1.11 ± 0.05 | 4.80 ± 0.11 | 114.37 ± 2.82 |
| CCl4 | 6.95 ± 0.59* | 2.19 ± 0.20* | 52.09 ± 2.65* |
| Silymarin | 2.26 ± 0.18* | 4.14 ± 0.15* | 99.99 ± 3.70* |
| 50 mg/kg | 5.69 ± 0.24 | 2.35 ± 0.20 | 57.48 ± 2.18 |
| 100 mg/kg | 4.17 ± 0.04* | 2.85 ± 0.20 | 67.66 ± 2.99* |
| 150 mg/kg | 3.09 ± 0.09* | 3.31 ± 0.13* | 78.44 ± 3.43* |
| 200 mg/kg | 1.79 ± 0.27* | 4.67 ± 0.43* | 83.83 ± 4.88* |
All values represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ANOVA, followed by Dunnett’s multiple comparison test.
As compared with Control group.
As compared with CCl4 only group.
Fig. 1Light microscope pictures liver tissues stained with i Mayer’s hematoxylin stain ii: Masson trichrome technique iii: Periodic Acid Schiff – Hematoxylin (PAS-H), (a) Liver cells of normal control group. (b) Liver cells of CCl4 treated group i: Degenerative liver tissue, necrosis accompanied by occlusion of blood. ii: Large amount of collagen fibers taking the blue colour. iii: Absence of PAS positive materials which indicates illed hepatocyte with very low functioning capacity. (c) Liver cells of CCl4 & silymarin treated group i: Clear evidence of healing and regaining microanatomical architecture of liver tissue. Hyperemia still appears in some central veins without complete occlusion ii: Improvement by lowering the amount of collagen fiber but not completely disappeared iii: Very few amount near to absence of PAS positive materials. (d) Liver cells of CCl4 & 150 mg treated group i: Healing process start but still degeneration and necrosis and hyperemia in central veins ii: Moderate amount of collagen fibers iii: Moderate amount of PAS positive materials which indicates healing starts but cells did not completely recovery. (e) Liver cells of CCl4 & 200 mg treated group i: ii: iii: All shows complete recovery and almost normal cells appearance.
Fig. 2Electron microscope pictures of liver tissues i: General ii: Nuclear study iii: Cytoplasmic study. (a) Liver cells of normal control group. (b) Liver cells of CCl4 treated group i: Degeneration and necrosis of hepatocytes. Also increased presence of vacuoles ii: Unusual multiple clumps of chromatin materials iii: Abnormal pattern of dissolved Golgi apparatus. (c) Liver cells of CCl4 & silymarin treated group i: Intact cellular and nuclear membrane associated with decreased amount of cytoplasmic vacuolization and normal presence of fat droplets ii: High healing activity by regaining many normal nuclei without clumps iii: Normal cytoplasm with normal Golgi apparatus and very few small fat droplets are present in cytoplasm. (d) Liver cells of CCl4 & 150 mg treated group i: Normal cells with moderate regaining of functioning cytoplasm. Also, shows cells with remaining effects of degeneration and necrosis. ii: Moderate improvement and healing activity by regaining intact nuclear membrane but still uneven distribution of chromatin material in the nucleus (i.e. some clumps remains) iii: Cytoplasm shows degenerated pattern of Golgi apparatus, weak cytoplasmic production and very few fat materials but no fat droplets. (e) Liver cells of CCl4 & 200 mg treated group i: Almost normal appearance of nucleus, functioning cytoplasm and fat droplets ii: Very high improvement and healing activity by regaining intact nuclear membrane and even distribution of chromatin material in the nucleus. iii: Cytoplasm shows normal pattern of Golgi apparatus, normal production of cytoplasm and very few fat materials but no fat droplets.